Loading...

Home
ETF
SLDB

SLDB

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

SLDB News

Guggenheim Initiates Buy Rating on Solid Biosciences Amid Approval Potential

Mar 20 2026seekingalpha

Solid Biosciences Reports Q4 Earnings Miss with Cash Growth

Mar 19 2026seekingalpha

Market Fluctuations: Oracle's Strong Performance Amid Geopolitical Risks

Mar 11 2026Yahoo Finance

Solid Biosciences Updates on SGT-003 Clinical Trial Data

Mar 11 2026Benzinga

Solid Biosciences Shares Drop After Clinical Data Release

Mar 11 2026seekingalpha

FDA CBER Head Dr. Vinay Prasad to Depart, Impact on Moderna and Rare Disease Stocks

Mar 09 2026Benzinga

Relmada Therapeutics Shares Surge 40.8% on Promising Trial Data

Mar 09 2026Benzinga

Marvell Technology Surges After Strong Q4 Earnings Report

Mar 06 2026Benzinga

Solid Biosciences Secures $240 Million Private Placement

Mar 06 2026seekingalpha

Solid Biosciences Secures $240 Million Private Placement Financing

Mar 06 2026Newsfilter

Solid Biosciences Receives Positive FDA Feedback

Feb 09 2026NASDAQ.COM

Solid Biosciences Aligns with FDA on Late-Stage Trial for DMD Treatment

Feb 09 2026seekingalpha

Solid Biosciences Aligns with FDA to Advance SGT-003 for Duchenne

Feb 09 2026Newsfilter

Solid Biosciences CEO to Present at Biotech Summit 2026

Feb 06 2026Newsfilter

Sarepta Shares Rise as 3-Year Elevidys Study Results Offer Promise.

Jan 26 2026Barron's

Solid Biosciences (SLDB) Completes Enrollment for SGT-003 Clinical Trial

Jan 14 2026seekingalpha